A detailed history of Oracle Alpha Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Oracle Alpha Inc. holds 3,348 shares of JNJ stock, worth $535,211. This represents 0.95% of its overall portfolio holdings.

Number of Shares
3,348
Previous 4,368 23.35%
Holding current value
$535,211
Previous $685 Million 22.64%
% of portfolio
0.95%
Previous 0.89%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$155.22 - $162.74 $158,324 - $165,994
-1,020 Reduced 23.35%
3,348 $530 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $635,980 - $693,987
4,368 New
4,368 $685 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $418B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Oracle Alpha Inc. Portfolio

Follow Oracle Alpha Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Alpha Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oracle Alpha Inc. with notifications on news.